Literature DB >> 6967583

Meningitis due to Haemophilus influenzae type b resistant to both ampicillin and chloramphenicol.

J F Kenny, C D Isburg, R H Michaels.   

Abstract

A strain of Haemophilus influenzae type b with considerable resistant to both ampicillin and chloramphenicol was recovered from a South Dakota child with meningitis. There was an initial lack of response to conventional doses but the child improved after a brief period of 200 mg/kg/day of chloramphenicol. The organism showed in vitro resistance to ampicillin, carbenicillin, tetracycline, and chloramphenicol (for each antibiotic the minimal inhibitory concentration (MIC) was 8 micrograms/ml or greater with a bacterial challenge of 10(5) colony-forming units (CFU)/ml), but it was sensitive to both streptomycin and rifampin (MIC 1.6 micrograms/ml, respectively). Isobolograms constructed from the results of testing various concentrations of ampicillin and chloramphenicol showed additive effects with high bacterial inocula (10(5) or 10(7) CFU/ml), but antagonism with low inocula (10(2) or 10(4) CFU/ml).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6967583

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  32 in total

1.  Use of commercially available rapid chloramphenicol acetyltransferase test to detect resistance in Salmonella species.

Authors:  L de la Maza; S I Miller; M J Ferraro
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

2.  Comparative activities of LY 164846 and other orally administered beta-lactam antibiotics against Haemophilus influenzae.

Authors:  J H Jorgensen; J S Redding; A W Howell
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

3.  Combined action of chloramphenicol and ampicillin on chloramphenicol-resistant Haemophilus influenzae.

Authors:  A M Mackenzie; F T Chan
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

4.  Disk diffusion interpretive criteria for extended-spectrum cephalosporins with Haemophilus influenzae.

Authors:  J H Jorgensen; L A Maher; J S Redding
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

5.  Pharmacokinetics and therapeutic efficacy of imipenem, ceftazidime, and ceftriaxone in experimental meningitis due to an ampicillin- and chloramphenicol-resistant strain of Haemophilus influenzae type b.

Authors:  Y Sakata; G H McCracken; M L Thomas; K D Olsen
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

6.  Mechanism of resistance of an ampicillin-resistant, beta-lactamase-negative clinical isolate of Haemophilus influenzae type b to beta-lactam antibiotics.

Authors:  T R Parr; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

7.  Cloning and expression of genes responsible for altered penicillin-binding proteins 3a and 3b in Haemophilus influenzae.

Authors:  F Malouin; A B Schryvers; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

8.  Pharmacokinetics of cefuroxime in infants and children with bacterial meningitis.

Authors:  M de los A del Rio; D F Chrane; S Shelton; G H McCracken; J D Nelson
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

9.  Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.

Authors:  G H McCracken; J D Nelson; L Grimm
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

10.  Single-dose pharmacokinetics of ceftriaxone in infants and young children.

Authors:  U B Schaad; K Stoeckel
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.